` PCR (PCC Rokita SA) vs WIG20 Comparison - Alpha Spread

P
PCR
vs
W
WIG20

Over the past 12 months, PCR has underperformed WIG20, delivering a return of -8% compared to the WIG20's +28% growth.

Stocks Performance
PCR vs WIG20

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
PCR vs WIG20

Performance Gap Between PCR and WIG20
HIDDEN
Show

Performance By Year
PCR vs WIG20

Loading
PCR
WIG20
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
PCC Rokita SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

PCC Rokita SA
Glance View

Market Cap
1.4B PLN
Industry
Chemicals

PCC Rokita SA engages in the sale and production of chemical products. The company is headquartered in Brzeg Dolny, Woj. Dolnoslaskie and currently employs 1,791 full-time employees. The company went IPO on 2014-06-25. The company divides its business into three segments: Chemicals that includes manufacture of such products as polyols, comprising polyether polyols for the production of polyurethane polymers, among others; chloralkali, including chlorine and soda lye; chlorobenzene, such as monochlorobenzene, dichlorobenzene and technical hydrochloric acid; phosphorus derivates; and naphthalene derivates; Energy engaged in the production and distribution of electric and thermal energy, demineralized water and compressed air; and Other Activities composed of assembly and maintenance of industrial armature, technical monitoring and consulting services, waste management, among others.

PCR Intrinsic Value
HIDDEN
Show
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett